Clinical trials

  • GEMTUZUMAB OZOGAMICIN for Acute myeloid leukaemia (AML) | Myelodysplastic syndrome (high-risk) | Myeloid sarcoma
  • RhinoPHAGE-2A cocktail for Chronic rhinosinusitis|Staphylococcus aureus infection
  • CISPLATIN for Hepatoblastoma | Hepatocellular carcinoma
  • Autologous CD34+ haematopoietic stem and progenitor cells transduced with a lentiviral vector encoding the interferon alpha-2 gene for Glioblastoma multiforme
  • RUXOLITINIB for Polycythemia vera
  • AUTOLOGOUS TUMOUR-INFILTRATING LYMPHOCYTES for Germ cell tumor | Germ cell tumor refractory to salvage chemotherapy
  • CISPLATIN for Oropharyngeal squamous cell carcinoma | Oropharyngeal cancer
  • AZD4512 for B-cell acute lymphoblastic leukemia (B-ALL)
  • CAPECITABINE for Early stage colorectal cancer
  • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE for Colorectal cancer|Cancer cachexia
  • Ruxolitinib for Primary haemophagocytic lymphohistiocytosis (HLH)
  • recombinant varicella zoster virus glycoprotein E for Herpes zoster